Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas.
about
Upregulation of NHE1 protein expression enables glioblastoma cells to escape TMZ-mediated toxicity via increased H⁺ extrusion, cell migration and survival.PAK5-Egr1-MMP2 signaling controls the migration and invasion in breast cancer cell.The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival in hepatocellular carcinoma.Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitorsCalycosin inhibits migration and invasion through modulation of transforming growth factor beta-mediated mesenchymal properties in U87 and U251 cellsAdenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma.Quercetin suppresses cellular migration and invasion in human head and neck squamous cell carcinoma (HNSCC)Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.Gene expression analysis of an EGFR indirectly related pathway identified PTEN and MMP9 as reliable diagnostic markers for human glial tumor specimensATF3 reduces migration capacity by regulation of matrix metalloproteinases via NFκB and STAT3 inhibition in glioblastomaA complete compilation of matrix metalloproteinase expression in human malignant gliomas.Circulating biomarkers of CNS tumors: an update.Emerging circulating biomarkers in glioblastoma: promises and challenges.Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9.The hemopexin domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice.Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands.Histamine induces the production of matrix metalloproteinase-9 in human astrocytic cultures via H1-receptor subtype.Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion.Freiburg neuropathology case conference: widespread mass lesions after resection of a glioblastoma multiforme.Targeting Netrin-1 in glioblastoma stem-like cells inhibits growth, invasion, and angiogenesis.Granulocyte-colony stimulating factor promotes proliferation, migration and invasion in glioma cells.Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway.Quantitative analysis of matrix metalloproteinase-2 mRNA expression in central and peripheral regions of gliomas.The siRNA silencing of DcR3 expression induces Fas ligand-mediated apoptosis in HepG2 cells.Matrix metalloproteinase 2 attenuates brain tumour growth, while promoting macrophage recruitment and vascular repair.
P2860
Q30586379-D5B46B60-C473-4C8A-8E01-FAA8C0251A4DQ34346022-3CBE6D47-3A8F-4187-AAE7-338FD4EE373FQ34612059-7C359A95-7764-4F1C-8980-AA4E8F6F3FDBQ35871254-622FAF3F-0F58-4445-8803-6F2A457D3D3BQ36624137-D103A8F9-092E-44D1-976F-4A3820ED77D4Q36952294-83405213-4E42-45A3-B602-EFC9B2F23091Q37165861-E68D2A2E-E17B-48B2-8A78-BFCB47E6E0E4Q37236243-22BC58B0-C198-4B51-B0E8-68CA42A866C8Q37282343-4E290C22-FBC6-4B4B-B9B8-EA7323144793Q37668192-7ACB79D5-D73D-4D99-8C27-23A23F6379B0Q38009800-23B1350E-9FDB-4D74-9F70-8C9BE51D8F12Q38095109-90AEAE94-C258-495B-89E1-2DFC0EC2D0C4Q38591062-7872F167-AB66-4248-B062-B716E7F63D2CQ39215770-9AB8F1EE-97C9-49FC-B052-FAC509A5D876Q39889999-D788E830-B3A9-4542-A997-7787F3C686CEQ39926498-6C3CA503-5DFC-45B5-99E6-198937B046BCQ40145204-7EA3E0C9-73FA-406F-8C44-0A9C6375370BQ42705828-C59919AC-B3AC-4E77-BAAD-1C283756EA2CQ46772676-0A5C3730-53F6-4384-9A87-1120851EC8C6Q47415825-F241D37B-7AB1-4F41-A004-45271D4E9858Q48305605-BD7B9B39-CB3A-493B-8B17-06190C3938BEQ48502109-382657D7-5813-45CF-B767-E60591303D1FQ48669602-75BF70AA-337C-4472-85BA-BB792774E9F7Q49118867-6FC9928D-F1F2-4FD5-8106-AF887CD8C412Q53089129-8C29133D-3611-4346-8782-89D07C8F6D1AQ54387106-63E0924A-A4FA-4539-804B-C4C3F4709020Q54958616-FF254C67-A51E-4A63-8912-F1CC8BDE19EBQ55463274-9D264D10-C534-4827-8B8A-953F1AD7868D
P2860
Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Expression and quantitative an ...... ase-2 and -9 in human gliomas.
@en
Expression and quantitative an ...... ase-2 and -9 in human gliomas.
@nl
type
label
Expression and quantitative an ...... ase-2 and -9 in human gliomas.
@en
Expression and quantitative an ...... ase-2 and -9 in human gliomas.
@nl
prefLabel
Expression and quantitative an ...... ase-2 and -9 in human gliomas.
@en
Expression and quantitative an ...... ase-2 and -9 in human gliomas.
@nl
P2093
P2860
P356
P1476
Expression and quantitative an ...... ase-2 and -9 in human gliomas.
@en
P2093
Kyoko Komatsu
Makio Kobayashi
Norimichi Nemoto
Tatsuo Sawada
Tomokatsu Hori
Yoko Nakanishi
P2860
P2888
P304
P356
10.1007/BF02482184
P577
2004-01-01T00:00:00Z